what is glp 1 receptor agonist GLP-1 agonists show promise in treating substance use disorders GLP-1 receptor agonists for individualized
Description
As concerns liraglutide, Armstrong et al
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis - Study design and rationale of HM-TRIA-201 study
And while the study compared GLP-1 RAs broadly (not tirzepatide specifically), tirzepatide is a GLP-1 RA with additional GIP activity that may confer extra cardiovascular benefit
Slowed gastric emptying, weight loss, and favorable results on lipid parameters have all been associated with GLP-1RAs use [40]
Response rates tell you something different
doi: 10.2337/db12-0797
